Michael B. McNulty
Nessuna posizione attualmente
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Brett Frevert | M | 61 |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | 2 anni |
Edward Barnholt | M | 81 | 6 anni | |
Michael Tang | M | 50 | - | |
Robert M. Patzig | M | 55 |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | - |
Doit L. Koppler | M | 61 |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | 7 anni |
Paul Clark | M | 76 | 15 anni | |
Gregory T. Sloma | M | 71 |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | 6 anni |
Jan C. Fagerberg | M | 62 | 1 anni | |
Adrian Dillon | M | 70 | 9 anni | |
Antonius P. Schuh | M | 59 |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | 5 anni |
D. Craig Nordlund | M | 74 | 10 anni | |
Jessica Denecour | F | 62 | 6 anni | |
Herb F. Ostenberg | M | 74 | 10 anni | |
Barney E. Saunders | M | 61 | 4 anni | |
Stephen D. Williams | M | 52 | 9 anni | |
Murali M. Ramalingam | M | - | - | |
Katherine A. Richardson | M | - |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | - |
Homayoon Haddad | M | - | 22 anni | |
Anya Yudin-Baehrle | F | - | 10 anni | |
James P. Yano | M | 57 | 4 anni | |
Hong Kiat Leong | M | - | 5 anni | |
Eric P. Kaldjian | M | 62 |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | 3 anni |
Eric Johnson | M | - |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | 1 anni |
Gregory Matz | M | 64 | 11 anni | |
Byron J. Anderson | M | 79 | 5 anni | |
Yih-Neng Lee | M | 65 | 4 anni | |
Abhishek Shukla | M | - | 5 anni | |
Sidhant Dua | M | - | 1 anni | |
Carl Raimond | M | 53 | 5 anni | |
Brad Nelson | M | - | 2 anni | |
David Hwang | M | - | - | |
Lynne J. Camp | F | 66 | 10 anni | |
Matthew Randall | M | - | 5 anni | |
Yvonne Linney | M | 62 | 9 anni | |
Kah Khim Wee | M | 55 | 11 anni | |
Patrick Finn | M | 53 | 2 anni | |
Liang Horng Wang | M | - | 2 anni | |
Bill James Peck | M | 64 | 8 anni | |
Emily Leproust | M | 50 | 4 anni | |
John Skinner | M | 62 | 4 anni | |
Ingrid Estrada | F | 60 | - | |
Michael T. Wende | M | 66 | 11 anni | |
Alan Grahame | M | 71 | 8 anni | |
Tze-Siong Chong | M | - | 8 anni | |
Michael Vargas | M | 64 | 5 anni | |
Hans-Joachim Wagner | M | 64 | 8 anni | |
Kristen Robinson | F | 61 | 6 anni | |
Earl R. Thompson | M | 62 | 5 anni | |
Hungwen Li | M | 73 | 1 anni | |
William A. Tomeo | M | 73 | 1 anni | |
Dietmar Höller | M | 66 | 6 anni | |
Paul M. Barics | M | 61 | 5 anni | |
Pascal Rondé | M | 62 | 6 anni | |
Gayn Erickson | M | 59 | 2 anni | |
Robert L. Joss | M | 82 | 7 anni | |
Patrick Byrne | M | 63 | 8 anni | |
Sharon Holt | F | 59 | 5 anni | |
Nicolas Roelofs | M | 66 | 7 anni | |
John R. Pouk | M | - | - | |
David J. Allen | M | 69 | 7 anni | |
Christopher van Ingen | M | 77 | 6 anni | |
Patrick Kaltenbach | M | 60 | 10 anni | |
Young Sohn | M | 68 | 2 anni | |
Anthony Salerno | M | 70 | 5 anni | |
Andrew Caminschi | M | 48 | 3 anni | |
Amir Aghdaei | M | 66 | 7 anni | |
Ram Krishnan | M | 70 | 2 anni | |
Julie Ione Morris | F | - | 7 anni | |
Aislinn Rice | M | - | 2 anni | |
Martin Scott | M | 68 | 6 anni | |
Jorge Nigaglioni | M | 52 | 4 anni | |
Robert Nail | M | 50 | 2 anni | |
Jeffrey L. Sklar | M | 76 |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | 13 anni |
Sonia Clark | F | 59 | 1 anni | |
Ron Torten | M | 57 | 1 anni | |
Robert Schueren | M | 62 | 3 anni | |
David S. Churchill | M | 66 | - | |
Michael W. Mercer | M | - |
Berkeley HeartLab, Inc.
Berkeley HeartLab, Inc. Medical/Nursing ServicesHealth Services Berkeley HeartLab Inc. operates as a cardiovascular healthcare company. It provides cardiovascular disease management tools and services, with focus on the secondary prevention market. The company was founded by Robert H. Superko in 1995 and is headquartered in CA. | - |
Keith Barnes | M | 72 | - | |
Susan Knowles | F | - | 1 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 80 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Michael B. McNulty
- Contatti personali